Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) Shareholder Notice: Investigation of Takeover
An investigation on behalf of investors, who currently hold shares of Kythera Biopharmaceuticals Inc (NASDAQ:KYTH), was announced concerning whether the takeover of Kythera Biopharmaceuticals Inc by Allergan plc for a value of $75 per share is unfair to NASDAQ:KYTH stockholders.
View full press release